Live Breaking News & Updates on Research institute for biological safety problems

Stay informed with the latest breaking news from Research institute for biological safety problems on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Research institute for biological safety problems and stay connected to the pulse of your community

And Then There Were 31...The Latest 10 Covid Vaccines to Reach the Phase 3 Results Milestone

And Then There Were 31...The Latest 10 Covid Vaccines to Reach the Phase 3 Results Milestone
plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.

Kazakhstan , Malaysia , Australia , Taiwan , Japan , Philippines , United-states , United-kingdom , Iran , Cuba , Vietnam , Republic-of

Pentagon Unit A1266 studies bioterrorism agents in Kazakhstan - right on Russia and China's doorstep -- Puppet Masters -- Sott.net

American military scientists from the US Navy Medical Research Center, Silver Spring, Maryland have studied bioterrorism agents in Pentagon biolaboratories in Kazakhstan, scientific papers reveal. The Pentagon Unit A1266 along with local...

Iran , Kazakhstan , Georgia , United-states , Mongolia , Japan , Afghanistan , Fort-collins , Colorado , Almaty , Almaty-qalasy , Inner-mongolia

January 25. Kazinform's timeline of major events

NUR-SULTAN. KAZINFORM - Kazinform's Timeline is the one-stop shop where you can learn about historical events for the 25th of January. See what notable events happened throughout Kazakhstan's history on January 25.

Caspian-sea , Oceans-general- , Oceans , Kazakhstan , Davos , Switzerland-general- , Switzerland , Almaty , Almaty-qalasy , Petersburg , Sankt-peterburg , Russia

EClinicalMedicine published by The Lancet releases results of Kazakhstan's QazVac clinical trials

NUR-SULTAN. KAZINFORM – Minister of Education and Science of the Republic of Kazakhstan Askhat Aimagambetov revealed that the results of clinical trials of Kazakhstan’s homegrown vaccine QazVac (QazCovid-in) will appear in EClinicalMedicine published by The Lancet magazine, Kazinform reports.

Kazakhstan , Republic-of-kazakhstan , Askhat-aimagambetov , Research-institute-for-biological-safety-problems , Facebook , Kazakhstan-askhat-aimagambetov , Research-institute , Biological-safety-problems , Qazvac , Qazcovid-in , Coronavirus , Eclinicalmedicine

COVID-19 vaccine quandary for international students

COVID-19 vaccine quandary for international students
universityworldnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from universityworldnews.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Chumakov , Stavropol-skiy-kray , Russia , France , Russian , Anhui-zhifei-longcom , Russian-academy-of-sciences-do , Institute-of-biological-products-sinopharm , Pfizer , Research-institute-for-biological-safety-problems

COVID-19: There are more vaccines in the making

COVID-19: There are more vaccines in the making
gulfnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulfnews.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Kazakhstan , Munich , Bayern , Germany , United-kingdom , Beijing , China , Osaka , Japan , India

When 3rd stage of QazVac clinical trials will be finished

NUR-SULTAN. KAZINFORM – Kunsulu Zakarya, Director General of the Research Institute for Biological Safety Problems, revealed when the third stage of clinical trials of Kazakhstan’s QazCovid-in (QazVac) vaccine will be finished, Kazinform correspondent reports.

Kazakhstan , Republic-of-kazakhstan , Kunsulu-zakarya , Research-institute-for-biological-safety-problems , Director-general , Research-institute , Biological-safety-problems , Qazvac , Qazcovid-in , Coronavirus-vaccine , 3rd-stage , Clinical

Despite Assurances, Some Kazakhs Leery Of Little-Known, Homegrown COVID-19 Vaccine


share
Print
NUR-SULTAN -- The fact that it hasn't completed its clinical trials hasn't stopped thousands of Kazakh citizens from getting their first shot of the domestically developed coronavirus vaccine QazVac.
The two-dose vaccine is still in its third stage of studies, which are expected to be completed in July. But QazVac's developers -- the state-backed Research Institute for Biological Safety Problems -- insists the vaccine is safe and effective.
The institute claims QazVac has shown a 96 percent efficacy against the virus during second-phase testing.
No serious side effects have been reported among the vaccine recipients since the QazVac rollout began on April 26. The Health Ministry says 50,000 doses of QazVac have been distributed across the Central Asian country of nearly 19 million people.

Kazakhstan , Beijing , China , Kazakh , Zhambyl , Prague , Praha , Hlavníesto , Czech-republic , Almaty , Almaty-qalasy , India

Vaccinations Progress Slowly in Central Asia


Advertisement
Kazakhstan is a regional leader on vaccinations, but that’s not saying terribly much as vaccine rollouts across Asia have proceeded at slow paces relative to Western countries. Meanwhile, reports from Kazakhstan cite bureaucratic hurdles, hesitancy, and a lack of access to data about the country’s domestically-developed vaccine.
To date around 8.3 percent of the Kazakh population, or around 1.4 million people, have received at least one dose of a COVID vaccine. That figure has grown at a steep curve in recent weeks on the back of the availability of domestically produced doses of the Russian vaccine, Sputnik V, in addition to imported doses. 

Kazakhstan , Kyrgyzstan , Japan , India , Uzbekistan , China , United-arab-emirates , Russia , South-korea , Tajikistan , Russian , Chinese